PL 34231
Alternative Names: LA-12; PLD-147Latest Information Update: 16 Aug 2007
At a glance
- Originator PLIVA d.d.
- Class
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 11 Nov 2004 Phase Ib trial in Solid tumours in Czech Republic (PO)
- 16 Mar 2004 Phase-I clinical trials in Solid tumours in Czech Republic (PO)
- 05 Feb 2003 Preclinical trials in Solid tumours in Czech Republic (PO)